Sex Differences in Circulating Biomarkers of Heart Failure
- 7 December 2023
- journal article
- review article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 21 (1) , 11-21
Abstract
Purpose of RevSiew Evidence is scaling up for sex differences in heart failure; however, clinical relevance of sex-specific differential thresholds for biomarkers is not clearly known. Current ambiguity warrants a further look into the sex-specific studies on cardiac biomarkers and may facilitate understanding of phenotypic presentations, clinical manifestations, and pathophysiologic pathway differences in men and women. Recent Findings Recent studies have confirmed the fact that females have differential threshold for biomarkers, with lower troponin and higher NT proBNP levels. Ambiguity continues to exist in the clinical relevance of ST-2, Galectin 3, and other biomarkers. Novel biomarkers, proteomic biomarkers, and circulating micro RNAs with machine learning are actively being explored. Biomarkers in HFpEF patients with higher female representation are evolving. In recent clinical trials, sex-related difference in biomarkers is not seen despite therapeutic intervention being more effective in females compared to males. Summary Sex-related difference exists in the expression of biomarkers in health and in various disease states of heart failure. However, this differentiation has not effectively translated into the clinical practice in terms of diagnostic studies or prognostication. Active exploration to bridge the knowledge gap and novel technologies can shed more light in this area.Keywords
This publication has 81 references indexed in Scilit:
- Neurohormonal and clinical sex differences in heart failureEuropean Heart Journal, 2013
- Fatty acid binding protein 4 predicts left ventricular mass and longitudinal function in overweight and obese womenHeart, 2013
- Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart StudyClinical Chemistry, 2012
- Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection FractionCirculation: Heart Failure, 2012
- Reference Limits for N-Terminal-pro-B-Type Natriuretic Peptide in Healthy Individuals (from the Framingham Heart Study)The American Journal of Cardiology, 2011
- Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma — The Presage™ ST2 assayClinica Chimica Acta, 2009
- Associations Among Androgens, Estrogens, and Natriuretic Peptides in Young WomenJACC, 2007
- Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic PeptidesCirculation, 2005
- Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac DysfunctionCirculation, 2004
- Utility of B-Natriuretic Peptide in Detecting Diastolic DysfunctionCirculation, 2002